Artal Group as of March 31, 2022
Portfolio Holdings for Artal Group
Artal Group holds 136 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 7.8 | $185M | 588k | 315.31 | |
| Ww Intl | 6.3 | $152M | 15M | 10.23 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 6.2 | $149M | 71M | 2.09 | |
| Beigene Sponsored Adr (ONC) | 5.3 | $125M | 665k | 188.60 | |
| Mirati Therapeutics | 4.6 | $111M | 1.4M | 82.22 | |
| Alnylam Pharmaceuticals (ALNY) | 4.4 | $106M | 650k | 163.29 | |
| Seagen | 3.9 | $94M | 650k | 144.05 | |
| Fate Therapeutics (FATE) | 3.2 | $78M | 2.0M | 38.77 | |
| Seer Com Cl A (SEER) | 3.0 | $72M | 4.8M | 15.24 | |
| Morphic Hldg (MORF) | 2.8 | $66M | 1.7M | 40.15 | |
| Bellus Health Com New | 2.4 | $59M | 8.5M | 6.88 | |
| Igm Biosciences (IGMS) | 2.2 | $54M | 2.0M | 26.73 | |
| Cerevel Therapeutics Hldng I (CERE) | 2.2 | $53M | 1.5M | 35.01 | |
| Springworks Therapeutics (SWTX) | 2.0 | $48M | 850k | 56.44 | |
| Kymera Therapeutics (KYMR) | 1.8 | $42M | 1.0M | 42.32 | |
| Amicus Therapeutics (FOLD) | 1.6 | $38M | 4.0M | 9.47 | |
| Cytokinetics Com New (CYTK) | 1.5 | $37M | 1.0M | 36.81 | |
| Krystal Biotech (KRYS) | 1.4 | $33M | 500k | 66.54 | |
| Sage Therapeutics (SAGE) | 1.4 | $33M | 1.0M | 33.10 | |
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $32M | 2.5M | 12.89 | |
| Erasca (ERAS) | 1.1 | $27M | 3.2M | 8.60 | |
| Foghorn Therapeutics (FHTX) | 1.1 | $26M | 1.7M | 15.23 | |
| Schrodinger (SDGR) | 1.0 | $24M | 700k | 34.12 | |
| Relay Therapeutics (RLAY) | 0.9 | $21M | 700k | 29.93 | |
| Generation Bio | 0.9 | $21M | 2.8M | 7.34 | |
| Gossamer Bio (GOSS) | 0.9 | $21M | 2.4M | 8.68 | |
| Rubius Therapeutics | 0.9 | $20M | 3.7M | 5.51 | |
| Talaris Therapeutics | 0.9 | $20M | 2.1M | 9.84 | |
| Intellia Therapeutics (NTLA) | 0.8 | $20M | 275k | 72.67 | |
| Denali Therapeutics (DNLI) | 0.8 | $19M | 600k | 32.17 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $19M | 800k | 23.68 | |
| Evotec Sponsored Ads (EVO) | 0.7 | $17M | 1.1M | 15.13 | |
| Kura Oncology (KURA) | 0.7 | $17M | 1.1M | 16.08 | |
| Eqrx | 0.7 | $17M | 4.0M | 4.13 | |
| Allovir (ALVR) | 0.7 | $16M | 2.3M | 6.75 | |
| Replimune Group (REPL) | 0.6 | $15M | 900k | 16.98 | |
| Intel Corporation Call Option (INTC) | 0.6 | $15M | 300k | 49.52 | |
| Omega Therapeutics Common Stock (OMGAQ) | 0.6 | $14M | 2.3M | 6.24 | |
| Aptinyx | 0.6 | $14M | 6.1M | 2.27 | |
| I Mab Sponsored Ads (IMAB) | 0.6 | $14M | 850k | 16.24 | |
| Agenus Com New | 0.6 | $14M | 5.5M | 2.46 | |
| Iteos Therapeutics | 0.5 | $13M | 400k | 32.18 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $12M | 1.0M | 12.38 | |
| Praxis Precision Medicines I | 0.5 | $12M | 1.2M | 10.21 | |
| Kronos Bio | 0.5 | $11M | 1.5M | 7.23 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $10M | 200k | 50.81 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $10M | 700k | 14.24 | |
| Ikena Oncology (IKNA) | 0.4 | $9.5M | 1.5M | 6.10 | |
| Marinus Pharmaceuticals Com New | 0.4 | $9.4M | 1.0M | 9.35 | |
| Forma Therapeutics Hldgs SHS | 0.4 | $9.3M | 1.0M | 9.30 | |
| Atara Biotherapeutics | 0.4 | $9.3M | 1.0M | 9.29 | |
| Verve Therapeutics (VERV) | 0.4 | $9.1M | 400k | 22.82 | |
| Ambrx Biopharma Sponsored Ads | 0.4 | $8.9M | 2.2M | 4.12 | |
| Mersana Therapeutics | 0.4 | $8.8M | 2.2M | 3.99 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $8.5M | 500k | 16.90 | |
| Exscientia Ads (EXAI) | 0.3 | $7.9M | 550k | 14.40 | |
| Immunic (IMUX) | 0.3 | $7.9M | 700k | 11.30 | |
| Vigil Neuroscience (VIGL) | 0.3 | $7.9M | 1.1M | 7.03 | |
| Ovid Therapeutics (OVID) | 0.3 | $7.9M | 2.5M | 3.14 | |
| Sqz Biotech (SQZB) | 0.3 | $7.7M | 1.6M | 4.81 | |
| Tg Therapeutics (TGTX) | 0.3 | $7.6M | 800k | 9.51 | |
| Oatly Group Ab Sponsored Ads | 0.3 | $7.5M | 1.5M | 5.01 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.3 | $7.4M | 1.0M | 7.44 | |
| Omega Alpha Spac Cl A | 0.3 | $7.4M | 750k | 9.82 | |
| Leap Therapeutics | 0.3 | $7.0M | 4.0M | 1.75 | |
| Sea Sponsored Ads (SE) | 0.3 | $6.9M | 58k | 119.79 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $6.8M | 1.0M | 6.52 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $6.6M | 2.3M | 2.94 | |
| Design Therapeutics (DSGN) | 0.3 | $6.5M | 400k | 16.15 | |
| Immunocore Hldgs Ads (IMCR) | 0.3 | $6.0M | 200k | 29.90 | |
| Fusion Pharmaceuticals | 0.2 | $5.8M | 750k | 7.77 | |
| Contrafect Corp Com New | 0.2 | $5.5M | 1.5M | 3.65 | |
| Alpine Immune Sciences | 0.2 | $5.3M | 593k | 8.97 | |
| Stoke Therapeutics (STOK) | 0.2 | $5.3M | 250k | 21.05 | |
| Dyne Therapeutics (DYN) | 0.2 | $5.1M | 525k | 9.64 | |
| Neximmune | 0.2 | $5.1M | 1.2M | 4.21 | |
| Harpoon Therapeutics | 0.2 | $5.0M | 1.0M | 4.97 | |
| Dynamics Special Purpose Cor Class A Com | 0.2 | $4.9M | 500k | 9.87 | |
| Selecta Biosciences | 0.2 | $4.9M | 4.0M | 1.23 | |
| Instil Bio | 0.2 | $4.8M | 450k | 10.75 | |
| Y Mabs Therapeutics | 0.2 | $4.8M | 400k | 11.88 | |
| Avidity Biosciences Ord (RNA) | 0.2 | $4.6M | 250k | 18.47 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $4.6M | 1.6M | 2.77 | |
| Adagio Therapeutics (IVVD) | 0.2 | $4.6M | 1.0M | 4.56 | |
| Spero Therapeutics (SPRO) | 0.2 | $4.4M | 500k | 8.70 | |
| Hookipa Pharma Inc equity | 0.2 | $4.2M | 1.8M | 2.28 | |
| Syros Pharmaceuticals | 0.2 | $4.2M | 3.5M | 1.19 | |
| Mirion Technologies Com Cl A (MIR) | 0.2 | $4.0M | 500k | 8.07 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $4.0M | 1.0M | 4.00 | |
| Adverum Biotechnologies | 0.2 | $3.9M | 3.0M | 1.31 | |
| Portage Fintech Acquisitn Class A Ord Shs | 0.2 | $3.8M | 380k | 9.93 | |
| Solid Biosciences | 0.2 | $3.6M | 3.0M | 1.20 | |
| Graphite Bio | 0.1 | $3.6M | 700k | 5.10 | |
| Lyell Immunopharma | 0.1 | $3.5M | 700k | 5.05 | |
| Adagene Ads (ADAG) | 0.1 | $3.5M | 1.0M | 3.50 | |
| Vor Biopharma (VOR) | 0.1 | $3.3M | 550k | 6.04 | |
| Sana Biotechnology (SANA) | 0.1 | $3.3M | 400k | 8.26 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $3.2M | 450k | 7.16 | |
| Xilio Therapeutics (XLO) | 0.1 | $3.2M | 450k | 7.07 | |
| Curis Com New | 0.1 | $3.1M | 1.3M | 2.38 | |
| Gritstone Oncology Ord (GRTSQ) | 0.1 | $3.1M | 750k | 4.12 | |
| Cyclerion Therapeutics | 0.1 | $3.1M | 2.8M | 1.11 | |
| Zymeworks | 0.1 | $2.9M | 450k | 6.55 | |
| Immutep Sponsored Ads (IMMP) | 0.1 | $2.7M | 1.0M | 2.74 | |
| Cullinan Oncology (CGEM) | 0.1 | $2.6M | 250k | 10.47 | |
| 111 Ads | 0.1 | $2.6M | 966k | 2.66 | |
| Bridgebio Pharma (BBIO) | 0.1 | $2.5M | 250k | 10.15 | |
| 23andme Holding Class A Com | 0.1 | $2.5M | 661k | 3.83 | |
| Aravive | 0.1 | $2.5M | 1.3M | 1.93 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $2.1M | 400k | 5.34 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $2.1M | 750k | 2.76 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $2.0M | 1.0M | 2.00 | |
| Cardiff Oncology (CRDF) | 0.1 | $1.9M | 750k | 2.48 | |
| Axcella Health Inc equity | 0.1 | $1.8M | 713k | 2.57 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $1.7M | 1.5M | 1.12 | |
| Kinnate Biopharma | 0.1 | $1.4M | 125k | 11.26 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.1 | $1.4M | 111k | 12.58 | |
| Orchard Therapeutics Ads | 0.1 | $1.3M | 1.8M | 0.71 | |
| Codiak Biosciences | 0.1 | $1.3M | 200k | 6.27 | |
| Hippo Hldgs Common Stock | 0.0 | $1.2M | 600k | 1.99 | |
| Olema Pharmaceuticals (OLMA) | 0.0 | $1.1M | 261k | 4.26 | |
| XP Cl A (XP) | 0.0 | $1.1M | 35k | 30.11 | |
| Caribou Biosciences (CRBU) | 0.0 | $967k | 105k | 9.18 | |
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $964k | 75k | 12.85 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $880k | 200k | 4.40 | |
| Applied Therapeutics (APLT) | 0.0 | $844k | 400k | 2.11 | |
| Kaleido Biosciences Ord (KLDO) | 0.0 | $826k | 501k | 1.65 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $820k | 500k | 1.64 | |
| Mink Therapeutics | 0.0 | $652k | 290k | 2.25 | |
| Mei Pharma Com New | 0.0 | $603k | 1.0M | 0.60 | |
| Metacrine Ord | 0.0 | $564k | 925k | 0.61 | |
| Sigilon Therapeutics | 0.0 | $406k | 276k | 1.47 | |
| Yumanity Therapeutics | 0.0 | $326k | 217k | 1.50 | |
| Astria Therapeutics (ATXS) | 0.0 | $224k | 33k | 6.72 | |
| Ginkgo Bioworks Holdings Cl A Shs | 0.0 | $202k | 50k | 4.04 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $187k | 225k | 0.83 |